Miranda Jayne Toledano
First SEC filing: Jan. 11, 2022 · Latest: Jan. 11, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | ENTX | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 7, 2026 | ENTX | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 14, 2026 | ENTX | A | 72,993 | · | · | 847,135 Direct | +9.43% | Acquired | (price as of 2026-10-02) |
| July 14, 2026 | ENTX | A | 347,567 | · | · | 774,142 Direct | +81.48% | Acquired | (price as of 2026-10-02) |
| July 1, 2026 | DERM | A | 50,000 | · | · | 168,618 Direct | +42.15% | Acquired | (price as of 2026-10-02) |
| June 25, 2026 | DERM | A | 10,000 | · | · | 118,618 Direct | +9.21% | Acquired | (price as of 2026-10-02) |
| Dec. 29, 2025 | ENTX | P | 11,000 | $1.81 | $19,910 | 426,575 Direct | +2.65% | Acquired | 58.0% (price as of 2026-10-02) |
| Aug. 5, 2025 | DERM | A | 20,000 | · | · | 108,618 Direct | +22.57% | Acquired | (price as of 2026-10-02) |
| July 16, 2025 | ENTX | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 16, 2025 | ENTX | A | 43,860 | · | · | 415,575 Direct | +11.80% | Acquired | (price as of 2026-10-02) |
| July 16, 2025 | ENTX | A | 136,842 | · | · | 371,715 Direct | +58.26% | Acquired | (price as of 2026-10-02) |
| June 25, 2025 | DERM | A | 7,173 | · | · | 88,618 Direct | +8.81% | Acquired | (price as of 2026-10-02) |
| July 31, 2024 | ENTX | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 31, 2024 | ENTX | A | 124,121 | · | · | 234,873 Direct | +112.07% | Acquired | (price as of 2026-10-02) |
| July 8, 2024 | DERM | A | 9,728 | · | · | 81,445 Direct | +13.56% | Acquired | (price as of 2026-10-02) |
| Dec. 22, 2023 | ENTX | P | 23,952 | $0.12 | $2,874 | 23,952 Direct | · | Acquired | 2283.3% (price as of 2026-10-02) |
| Dec. 22, 2023 | ENTX | P | 23,952 | $0.71 | $17,006 | 110,752 Direct | +27.59% | Acquired | 302.8% (price as of 2026-10-02) |
| Sept. 13, 2023 | ENTX | A | 350,000 | · | · | 350,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 17, 2023 | NXGLW | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 21, 2023 | DERM | A | 27,472 | · | · | 71,717 Direct | +62.09% | Acquired | (price as of 2026-10-02) |
| April 4, 2023 | ENTX | P | 30,000 | $1.01 | $30,300 | 86,800 Direct | +52.82% | Acquired | 183.2% (price as of 2026-10-02) |
| Nov. 11, 2022 | ENTX | P | 50,000 | $0.53 | $26,500 | 56,800 Direct | +735.29% | Acquired | 439.6% (price as of 2026-10-02) |
| Sept. 7, 2022 | ENTX | A | 600,000 | · | · | 600,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 7, 2022 | ENTX | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 21, 2022 | DERM | A | 14,245 | · | · | 44,245 Direct | +47.48% | Acquired | (price as of 2026-10-02) |
| Jan. 14, 2022 | DERM | A | 30,000 | · | · | 30,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 14, 2022 | ENTX | P | 6,800 | $2.79 | $18,972 | 6,800 Direct | · | Acquired | 2.5% (price as of 2026-10-02) |
| Jan. 1, 2022 | ENTX | A | 107,557 | · | · | 107,557 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 1, 2022 | ENTX | A | 35,852 | · | · | 35,852 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 27, 2021 | NXGLW | A | 1,819 | $0.01 | $18 | 1,819 Direct | · | Acquired | 22.0% (price as of 2026-10-02) |
| Dec. 27, 2021 | NXGLW | P | 1,819 | $5.49 | $9,986 | 1,819 Direct | · | Acquired | -99.8% (price as of 2026-10-02) |
| June 25, 2021 | CMPX | J | 1,791,549 | · | · | 1,791,549 Direct | · | Acquired | (price as of 2026-10-02) |
| June 25, 2021 | CMPX | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | ENTX | Stock Option (right to buy) | Ordinary Shares, par value NIS 0.0000769 per share | $1.37 | May 6, 2036 | 500,000 | Acquired |
| Aug. 7, 2026 | ENTX | Stock Option (right to buy) | Ordinary Shares, par value NIS 0.0000769 per share | $2.81 | Aug. 7, 2036 | 200,000 | Acquired |
| July 16, 2025 | ENTX | Stock Option (Right to Buy) | Ordinary Shares, par value NIS 0.0000769 per share | $2.28 | April 28, 2035 | 500,000 | Acquired |
| July 31, 2024 | ENTX | Stock Option (Right to Buy) | Ordinary Shares, par value NIS 0.0000769 per share | $1.99 | April 19, 2034 | 500,000 | Acquired |
| Dec. 22, 2023 | ENTX | Warrants (right to buy) | Ordinary Shares, par value NIS 0.0000769 per share | · | Dec. 22, 2028 | 23,952 | Acquired |
| Sept. 13, 2023 | ENTX | Stock Option (right to buy) | Ordinary Shares, par value NIS 0.0000769 per share | $0.80 | April 24, 2033 | 350,000 | Acquired |
| Aug. 17, 2023 | NXGLW | Stock Option (Right to Buy) | Common Stock | $2.05 | Aug. 17, 2033 | 15,000 | Acquired |
| Sept. 7, 2022 | ENTX | Stock Option (right to buy) | Ordinary Shares, par value NIS 0.0000769 per share | $1.40 | July 15, 2032 | 600,000 | Acquired |
| Sept. 7, 2022 | ENTX | Stock Option (right to buy) | Ordinary Shares, par value NIS 0.0000769 per share | $2.02 | May 16, 2032 | 500,000 | Acquired |
| Jan. 1, 2022 | ENTX | Stock Option (right to buy) | Ordinary Shares, par value NIS 0.0000769 per share | $2.82 | Jan. 1, 2032 | 107,557 | Acquired |
| Jan. 1, 2022 | ENTX | Stock Option (right to buy) | Ordinary Shares, par value NIS 0.0000769 per share | $2.82 | Jan. 1, 2032 | 35,852 | Acquired |
| Dec. 27, 2021 | NXGLW | Warrant to Purchase Common Stock | Common Stock | $5.50 | Dec. 26, 2026 | 1,819 | Acquired |
| June 25, 2021 | CMPX | Stock Option (Right to Buy) | Common Stock, $.0001 Par Value | $4.90 | · | 50,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $490 | · | · | · | · | · | · | $1,482 |
| 2024 | $419 | · | · | $538 | · | · | $36 | $1,149 |
| 2023 | $338 | · | · | · | · | · | $80 | $950 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.